Trials / Completed
CompletedNCT05573568
Clinical Study of DMT in Healthy Adults
Inhaled N, N-Dimethyltryptamine: a Phase I Study in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Biomind Labs Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the acute and subacute effects of an inhaled N, N-Dimethyltryptamine in healthy individuals.
Detailed description
Participants will receive N, N-Dimethyltryptamine administered in two dosing sessions: an initial low-dose safety session and subsequent intermediate-dose treatment, in a fixed order and 2h apart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N,N-Dimethyltryptamine | DMT will be administered using a vaporizer device in a single ascending fixed-order dosing regimen |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-14
- First posted
- 2022-10-10
- Last updated
- 2023-02-15
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05573568. Inclusion in this directory is not an endorsement.